已收盤 10-08 16:00:00 美东时间
0.000
0.00%
Rein Therapeutics announced the publication of new data on LTI-03 in *iScience*, showing its potential as a breakthrough anti-fibrotic therapy for idiopathic pulmonary fibrosis (IPF). Tested on lung tissue from IPF patients, LTI-03 demonstrated reduction in scarring and inflammation, while avoiding cell damage. Unlike nintedanib, a current standard-of-care drug, LTI-03’s safety profile is strong. These findings support Rein’s Phase 2 RENEW trial,...
09-17 11:30
FOXO Technologies (NYSE:FOXO) announced that Seamus Lagan has been appointed CEO effectively immediately. Mr. Lagan joined the Board of Directors of the Company on September 10, 2024. Seamus Lagan, a...
2024-12-11 22:01
FOXO Technologies ( ($FOXO) ) has shared an announcement. Rennova Health, Inc. ...
2024-09-13 05:17
Rennova Health, Inc. Reports 7.63% Stake in Foxo Technologies Inc as of July 17...
2024-08-06 04:17
Rennova Health (RNVA) has issued an update. Rennova Health, Inc. has made strat...
2024-06-17 22:22
Rennova Health, Inc. Announces Stock Exchange Agreements With Foxo Technologies...
2024-06-17 20:30
On Friday before the market opened, FOXO Technologies announced that it entered into to two share exchange agreements with Rennova.
2024-06-14 22:16
Acquires Equity In Myrtle Recovery Centers For $500K In Common Stock And Rennova Community Health For $20M In Convertible Preferred Stock; Transactions Subject To Shareholder Approval; Combined Entities Generated $18.7M
2024-06-14 20:33